Planned pivotal phase III trial with BioPhage-PA for chronic otitis due to pseudomonal infections
Latest Information Update: 08 Nov 2012
At a glance
- Drugs AP PA01 (Primary)
- Indications Otorhinolaryngological infections; Pseudomonal infections
- Focus Registrational; Therapeutic Use
- 08 Nov 2012 New trial record